Bevacizumab-Induced Pneumonitis in a Patient With Metastatic Colon Cancer: A Case Report

Bevacizumab is a vascular endothelial growth factor–directed humanized monoclonal antibody used to treat many types of cancer and some eye diseases. Due to inhibition of angiogenesis, many adverse reactions such as bowel necrosis, nasal septal perforation, and renal thrombotic microangiopathy have b...

Descripción completa

Detalles Bibliográficos
Autores principales: Pervaiz, Sami, Homsy, Sylvester, Narula, Naureen, Ngu, Sam, Elsayegh, Dany
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7297475/
https://www.ncbi.nlm.nih.gov/pubmed/32595283
http://dx.doi.org/10.1177/1179548420929285

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7297475/
https://www.ncbi.nlm.nih.gov/pubmed/32595283
http://dx.doi.org/10.1177/1179548420929285

Ejemplares similares